The best doctor for prostate cancer isn’t a single specialist. It’s a team, anchored by a urologic oncologist, and the most important factor in choosing one is how many prostate cancer cases they manage each year. A surgeon who performs more than 39 prostatectomies per year has measurably better outcomes than one who does fewer than 15. That volume threshold, along with the institution behind the doctor, matters more than reputation or bedside manner alone.
Three Specialists Who Lead Treatment
Prostate cancer care typically involves three core physicians, each with a distinct role. A urologic oncologist handles diagnosis, biopsy, and surgery. A radiation oncologist designs and delivers radiation treatments. A medical oncologist manages systemic therapies like hormone treatment and chemotherapy for advanced disease. The best outcomes happen when all three collaborate through what’s called a multidisciplinary team, where your case is reviewed collectively rather than filtered through a single doctor’s perspective.
At dedicated prostate cancer units, treatment recommendations split more evenly between surgery and radiation (roughly 52% and 45%, respectively) compared to settings where a single specialist drives the decision. That balance matters because it means you’re more likely to get the treatment that fits your specific cancer rather than the treatment your doctor happens to specialize in.
Why Surgical Volume Is Critical
If surgery is part of your treatment plan, the number of procedures your surgeon performs each year is one of the strongest predictors of how well things go. A large population-based study divided surgeons into volume quartiles and found that patients treated by the highest-volume surgeons (more than 39 cases per year) were 46% less likely to be readmitted to the hospital and 31% less likely to need additional urologic procedures compared to patients of the lowest-volume surgeons (fewer than 15 cases per year).
These aren’t small differences. They translate directly into fewer complications like urinary problems and fewer follow-up surgeries. When you’re evaluating a surgeon, asking “How many radical prostatectomies do you perform each year?” is one of the most useful questions you can ask. A number above 39 puts them in the top tier. Below 15 should give you pause.
Robotic-assisted surgery has its own learning curve on top of general surgical experience. Even for an experienced robotic surgeon, performance on newer techniques continues to improve through the first 10 to 30 cases. This means you want someone who has not only completed the learning curve but operates well beyond it.
What to Look for in a Radiation Oncologist
Radiation treatment for prostate cancer has become highly technical, particularly with stereotactic body radiation therapy (SBRT), which delivers high doses in just a few sessions. The precision required is significant. Modern approaches use real-time motion tracking to follow the prostate during treatment, since even small shifts from breathing or bladder filling can move the target.
Specialized machines like the CyberKnife system track and adjust for movement in real time, while MR-guided systems combine imaging with radiation delivery so the treatment plan can be adapted on the spot based on your anatomy that day. If you’re considering radiation, look for a center that uses these advanced motion-management technologies and a radiation oncologist who treats prostate cancer as a significant part of their practice. The benchmark from leading prostate cancer units is a radiation oncologist who spends at least half their clinical time on prostate disease and treats a minimum of 25 prostate cancer patients per year.
The Institution Matters as Much as the Doctor
Where your doctor practices shapes the quality of care in ways that go beyond individual skill. NCI-designated Comprehensive Cancer Centers meet rigorous federal standards for research, treatment, and multidisciplinary collaboration. There are 57 of these centers across the country, and they’re where many of the newest treatments are developed and first offered to patients. About 400,000 people receive their cancer diagnosis at an NCI-designated center each year, and thousands enroll in clinical trials that provide access to treatments not yet widely available.
For urology specifically, the top-ranked hospitals according to U.S. News include Memorial Sloan Kettering Cancer Center in New York (scored 100 out of 100), NYU Langone Hospitals, Mayo Clinic in Rochester, and MD Anderson Cancer Center in Houston. Johns Hopkins, Cleveland Clinic, UCLA Medical Center, and Northwestern Memorial round out the top ten. These rankings factor in surgical outcomes, patient volume, technology, and specialist expertise.
You don’t necessarily need to travel to one of these institutions for all your care. Many offer remote consultations or can coordinate with your local oncologist. But for complex or high-risk cases, having at least one touchpoint with a major cancer center can meaningfully change your trajectory.
Why a Second Opinion Changes Treatment Plans
Getting a second opinion isn’t just about reassurance. It frequently changes the diagnosis itself. When prostate biopsy samples are reviewed by a specialized pathologist at a major cancer center, the Gleason score (the grading system that determines how aggressive your cancer appears) changes in 15% to 41% of cases. In one study of 497 cases, nearly 38% had a major discrepancy between the original reading and the second review. Among those, about two-thirds were upgraded to a more serious grade and one-third were downgraded.
These changes aren’t academic. A shift in Gleason score leads to a different treatment recommendation in 9% to 26% of cases. That could mean the difference between active surveillance and surgery, or between radiation and a more aggressive approach. If your biopsy was read by a general pathologist rather than one who specializes in prostate tissue, a second pathology review at a high-volume center is one of the highest-value steps you can take.
Questions to Ask Before Choosing a Doctor
When meeting with a potential specialist, a few specific questions can quickly reveal whether they’re the right fit:
- How many prostate cancer cases do you manage per year? Look for numbers well above the minimums: 100 or more cases for a urologic oncologist, 25 or more radiation treatments for a radiation oncologist, 50 or more for a medical oncologist.
- If surgery is recommended, how many radical prostatectomies do you perform annually? Above 39 puts them in the highest-volume category with the best complication rates.
- Will my case be reviewed by a multidisciplinary tumor board? This means multiple specialists weigh in on your treatment plan rather than a single doctor deciding alone.
- What are your rates for the side effects I care about most? For surgery, this means urinary continence and sexual function recovery. For radiation, bowel and urinary irritation. Surgeons who track and share their own outcomes data are generally more confident in their results.
- Do you offer clinical trials? Access to trials means the institution is actively involved in developing new treatments, and it may give you options beyond standard care.
Finding Clinical Trial Access
If your cancer is advanced or has returned after initial treatment, a doctor who leads clinical trials can offer therapies that aren’t available elsewhere. The National Cancer Institute maintains a searchable database of active prostate cancer trials that you can filter by location, age, and cancer stage. Doctors listed as principal investigators on Phase III trials are typically at the forefront of their field, working at NCI-designated centers or major academic institutions. Even if you don’t enroll in a trial, consulting with a physician who runs them ensures you’re hearing about the full range of options.